Neurometrix Inc (NURO)

[x1power]

You get some decent sports ads on TV, etc. that trainers are using this Quell to speed recovery of players worldwide, and past R/Splits history is irrelevant to future stock prices?

GSK bot itself super PR device vehicle to counter opioids drug-use epidemic challenges, for now pain relief via electronic device use.

Cloud data device use review and medical suggestions as to needed pain relief levels, is huge plus for NURO future sales increases.

Seems GSK has placed itself in pivot position to buy-out the Quell Patent and maybe all of NURO, if international and USA sales keep growing.

Now have to wait and see what NURO mmgt. has in store for shareholders.
If DC cannot get stop-gap spending bill in hand, by Friday, the overall stock market may response negatively and draw everything with it?